Loading clinical trials...
Loading clinical trials...
A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions
Conditions
Interventions
TAK-861
Locations
52
United States
Sleep Disorders Center of Alabama
Birmingham, Alabama, United States
Stanford Center for Sleep Sciences and Medicine
Redwood City, California, United States
SDS Clinical Trials, Inc.
Santa Ana, California, United States
Delta Waves LLC - Hunt - PPDS
Colorado Springs, Colorado, United States
Florida Pediatric Research Institute
Orlando, Florida, United States
Neurotrials Research
Atlanta, Georgia, United States
Start Date
April 5, 2023
Primary Completion Date
February 28, 2028
Completion Date
February 28, 2028
Last Updated
March 5, 2026
NCT07363720
NCT06809803
NCT06457945
NCT06251063
NCT05375890
NCT04820842
Lead Sponsor
Takeda
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions